ADHD/Stimulants

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/17

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 3:41 PM on 8/25/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

18 Terms

1
New cards

Atomoxetine

Strattera — Norepinephrine reuptake inhibitor (ADHD)

2
New cards

Atomoxetine PO/Function/Common Use

PO — Alters the activity of norepinephrine (NE) — Reduces the symptoms of ADHD

3
New cards

Atomoxetine Adverse Drug Reactions/Special Considerations

Increased suicide ideation risk in pediatric and young adults — Dry mouth, fatigue, mood swings, decreased appetite

4
New cards

Amphetamine-Dextroamphetamine

Adderall, Mydayis — CNS stimulant

5
New cards

Amphetamine-Dextroamphetamine PO/Function/Common Use

PO — Modulates dopamine (DA) and norepinephrine (NE) — Reduces the symptoms of ADHD

6
New cards

Amphetamine-Dextroamphetamine Adverse Drug Reactions/Special Considerations

High risks of abuse and physical dependence — Decreased appetite, weight loss, insomnia, nervousness — Class II controlled substance

7
New cards

Dexmethylphenidate

Focalin — CNS stimulant

8
New cards

Dexmethylphenidate PO/Function/Common Use

PO — Modulates dopamine (DA) and norepinephrine (NE) — Reduces the symptoms of ADHD

9
New cards

Dexmethylphenidate Adverse Drug Reactions/Special Considerations

High risks of abuse and physical dependence — Decreased appetite, weight loss, insomnia, nervousness — Class II controlled substance

10
New cards

Lisdexamfetamine

Vyvanse — CNS stimulant

11
New cards

Lisdexamfetamine PO/Function/Common Use

PO — Modulates dopamine (DA) and norepinephrine (NE) — Reduces the symptoms of ADHD

12
New cards

Lisdexamfetamine Adverse Drug Reactions/Special Considerations

High risks of abuse and physical dependence — Decreased appetite, weight loss, insomnia, nervousness — Class II controlled substance

13
New cards

Methylphenidate

Ritalin, Concerta, Metadate ER — CNS stimulant

14
New cards

Methylphenidate PO/Function/Common Use

PO — Modulates dopamine (DA) and norepinephrine (NE) — Reduces the symptoms of ADHD

15
New cards

Methylphenidate Adverse Drug Reactions/Special Considerations

High risks of abuse and physical dependence — Decreased appetite, weight loss, insomnia, nervousness — Class II controlled substance

16
New cards

Phentermine

Adipex-P, Lomaira — CNS stimulant + anorexiant

17
New cards

Phentermine PO/Function/Common Use

PO — Modulates dopamine (DA), norepinephrine (NE), and serotonin (5-HT) — Promotes weight loss (in conjunction with appropriate diet)

18
New cards

Phentermine Adverse Drug Reactions/Special Considerations

Rare: Pulmonary hypertension — Insomnia, dry mouth, taste disturbances, tremors — Class IV controlled substance